The new way for early detection
OUR VISION
Women • Health • First
At Nevia, we are focused on women's health.
Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
We believe in empowering women to take control of their health by providing them with the tools they need to live a healthy life. Our team is made up of passionate individuals with diverse backgrounds in healthcare, technology, and business.
Together, we are working towards a future where women's health is a top priority.
Our first indication: Ovarian Cancer
Ovarian cancer is also called “the silent killer".
More than 310,000 cases are diagnosed every year worldwide, and 75% of patients are diagnosed at late stages, resulting in less than 30% survival rates.
Therefore, there is a growing demand for early-diagnosis solutions.
Nevia's platform will save lives of women around the world by enabling early detection.
OUR SOLUTION
Simple swab
Nevia Database
Machine learning algorithms
Test score
Pipeline
Program
Indication
Development Stage
Nevia 001
Nevia 002
Nevia 003
Ovarian Cancer
Endometriosis
Stealth mode
Biobank
Clinical POC
FDA Aprroval
Why us
HLTH Diverse founders
Israeli femtech innovation leadership award
First Place Pitch Competition
Top 20 most promising companies
OUR INVESTORS
